From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company claims that akathisia is less prevalent among patients taking Fanapt than those taking other antipsychotics.
Enjoyed what you just read? Consider a donation to help us continue to produce content, provide up-to-date research news, offer continuing education courses, and continue building a community for exploring alternatives to the current paradigm of mental health. All donations are tax deductible.